MedPlus Health Services disclosed a two-day drug license suspension for a Telangana store, with a potential revenue impact of Rs. 0.16 lakhs.
The suspension order was received on April 2, 2026, for a store in Jangaon, Telangana, for violations under the Drugs and Cosmetics Act.
The company made the disclosure under SEBI LODR Regulation 30, confirming the event is not considered material to its operations.